In cancer, LRP2 exhibits context dependence: melanomas acquire LRP2, and its knockdown curtails proliferation, whereas several epithelial cancers epigenetically silence it, linking low expression to dedifferentiation and poor survival [8]. Here, LRP2 is linked to melanoma.